{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:04:55Z","timestamp":1792037095681,"version":"4.4.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T00:00:00Z","timestamp":1483660800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s10157-016-1363-8","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T10:35:54Z","timestamp":1483698954000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Mineral metabolism and cardiovascular disease in CKD"],"prefix":"10.1007","volume":"21","author":[{"given":"Hideki","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Joki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,6]]},"reference":[{"issue":"1","key":"1363_CR1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","volume":"58","author":"AK Cheung","year":"2000","unstructured":"Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58(1):353\u201362.","journal-title":"Kidney Int"},{"issue":"3","key":"1363_CR2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1542-4758.2009.00377.x","volume":"13","author":"AA Desai","year":"2009","unstructured":"Desai AA, Nissenson A, Chertow GM, Farid M, Singh I, Van Oijen MG, Esrailian E, Solomon MD, Spiegel BM. The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodial Int Symp Home Hemodial. 2009;13(3):347\u201359.","journal-title":"Hemodial Int Symp Home Hemodial"},{"issue":"19","key":"1363_CR3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527\u201339.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1363_CR4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000441583","volume":"40","author":"K Tsuruya","year":"2015","unstructured":"Tsuruya K, Eriguchi M, Yamada S, Hirakata H, Kitazono T. Cardiorenal syndrome in end-stage kidney disease. Blood Purif. 2015;40(4):337\u201343.","journal-title":"Blood Purif"},{"issue":"3","key":"1363_CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ki.2012.118","volume":"82","author":"K Kono","year":"2012","unstructured":"Kono K, Fujii H, Nakai K, Goto S, Shite J, Hirata K, Fukagawa M, Nishi S. Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease. Kidney Int. 2012;82(3):344\u201351.","journal-title":"Kidney Int"},{"issue":"1","key":"1363_CR6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2011.69","volume":"80","author":"D Russo","year":"2011","unstructured":"Russo D, Corrao S, Battaglia Y, Andreucci M, Caiazza A, Carlomagno A, Lamberti M, Pezone N, Pota A, Russo L, et al. Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int. 2011;80(1):112\u20138.","journal-title":"Kidney Int"},{"issue":"1","key":"1363_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2215\/CJN.05120610","volume":"6","author":"F Verbeke","year":"2011","unstructured":"Verbeke F, Van Biesen W, Honkanen E, Wikstrom B, Jensen PB, Krzesinski JM, Rasmussen M, Vanholder R, Rensma PL, Investigators CS. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol. 2011;6(1):153\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1363_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.ASN.0000038685.95946.83","volume":"14","author":"AY Wang","year":"2003","unstructured":"Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003;14(1):159\u201368.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1363_CR9","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM, et al. FGF23 induces left ventricular hypertrophy. J Clin Investig. 2011;121(11):4393\u2013408.","journal-title":"J Clin Investig"},{"issue":"6","key":"1363_CR10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359(6):584\u201392.","journal-title":"N Engl J Med"},{"issue":"1","key":"1363_CR11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/kisup.2015.5","volume":"5","author":"N Hanafusa","year":"2015","unstructured":"Hanafusa N, Nakai S, Iseki K, Tsubakihara Y. Japanese society for dialysis therapy renal data registry-a window through which we can view the details of Japanese dialysis population. Kidney Int Suppl. 2015;5(1):15\u201322.","journal-title":"Kidney Int Suppl"},{"key":"1363_CR12","unstructured":"United States Renal Data System. 2015 USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health NIoDaDaK."},{"issue":"4","key":"1363_CR13","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","volume":"65","author":"C Zoccali","year":"2004","unstructured":"Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int. 2004;65(4):1492\u20138.","journal-title":"Kidney Int"},{"issue":"12","key":"1363_CR14","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1681\/ASN.V12122759","volume":"12","author":"GM London","year":"2001","unstructured":"London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol. 2001;12(12):2759\u201367.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1363_CR15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2353\/ajpath.2010.091292","volume":"177","author":"J Kong","year":"2010","unstructured":"Kong J, Kim GH, Wei M, Sun T, Li G, Liu SQ, Li X, Bhan I, Zhao Q, Thadhani R, et al. Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats. Am J Pathol. 2010;177(2):622\u201331.","journal-title":"Am J Pathol"},{"issue":"11","key":"1363_CR16","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/ndt\/gft268","volume":"28","author":"S Panizo","year":"2013","unstructured":"Panizo S, Barrio-Vazquez S, Naves-Diaz M, Carrillo-Lopez N, Rodriguez I, Fernandez-Vazquez A, Valdivielso JM, Thadhani R, Cannata-Andia JB. Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis. Nephrol Dial Transpl. 2013;28(11):2735\u201344.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"1363_CR17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/ajh\/hpt177","volume":"27","author":"M Freundlich","year":"2014","unstructured":"Freundlich M, Li YC, Quiroz Y, Bravo Y, Seeherunvong W, Faul C, Weisinger JR, Rodriguez-Iturbe B. Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats. Am J Hypertens. 2014;27(5):720\u20136.","journal-title":"Am J Hypertens"},{"issue":"2","key":"1363_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Investig. 2002;110(2):229\u201338.","journal-title":"J Clin Investig"},{"issue":"2","key":"1363_CR19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000346808","volume":"37","author":"K Kono","year":"2013","unstructured":"Kono K, Fujii H, Nakai K, Goto S, Kitazawa R, Kitazawa S, Shinohara M, Hirata M, Fukagawa M, Nishi S. Anti-oxidative effect of vitamin D analog on incipient vascular lesion in non-obese type 2 diabetic rats. Am J Nephrol. 2013;37(2):167\u201374.","journal-title":"Am J Nephrol"},{"issue":"4","key":"1363_CR20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000319445","volume":"32","author":"K Husain","year":"2010","unstructured":"Husain K, Suarez E, Isidro A, Ferder L. Effects of paricalcitol and enalapril on atherosclerotic injury in mouse aortas. Am J Nephrol. 2010;32(4):296\u2013304.","journal-title":"Am J Nephrol"},{"issue":"4","key":"1363_CR21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/ndt\/gfi254","volume":"21","author":"M Cohen-Lahav","year":"2006","unstructured":"Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transpl. 2006;21(4):889\u201397.","journal-title":"Nephrol Dial Transpl"},{"issue":"17","key":"1363_CR22","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.111.032680","volume":"124","author":"S Chen","year":"2011","unstructured":"Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y, Gardner DG. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation. 2011;124(17):1838\u201347.","journal-title":"Circulation"},{"issue":"6","key":"1363_CR23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10557-015-6629-y","volume":"29","author":"H Fujii","year":"2015","unstructured":"Fujii H, Nakai K, Yonekura Y, Kono K, Goto S, Hirata M, Shinohara M, Nishi S, Fukagawa M. The vitamin D receptor activator maxacalcitol provides cardioprotective effects in Diabetes Mellitus. Cardiovasc Drugs Therapy\/Sponsored Int Soc Cardiovasc Pharmacother. 2015;29(6):499\u2013507.","journal-title":"Cardiovasc Drugs Therapy\/Sponsored Int Soc Cardiovasc Pharmacother"},{"issue":"7","key":"1363_CR24","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012;307(7):674\u201384.","journal-title":"JAMA"},{"issue":"1","key":"1363_CR25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","volume":"25","author":"AY Wang","year":"2014","unstructured":"Wang AY, Fang F, Chan J, Wen YY, Qing S, Chan IH, Lo G, Lai KN, Lo WK, Lam CW, et al. Effect of paricalcitol on left ventricular mass and function in CKD\u2014the OPERA trial. J Am Soc Nephrol. 2014;25(1):175\u201386.","journal-title":"J Am Soc Nephrol"},{"key":"1363_CR26","doi-asserted-by":"crossref","unstructured":"Tamez H, Zoccali C, Packham D, Wenger J, Bhan I, Appelbaum E, Pritchett Y, Chang Y, Agarwal R, Wanner C, et al. Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J. 2012; 164(6):902\u2013909 e902.","DOI":"10.1016\/j.ahj.2012.09.018"},{"issue":"6","key":"1363_CR27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","volume":"22","author":"A Grabner","year":"2015","unstructured":"Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, Li J, Shehadeh LA, Hare JM, David V, et al. Activation of cardiac fibroblast growth factor receptor 4 Causes left ventricular hypertrophy. Cell Metab. 2015;22(6):1020\u201332.","journal-title":"Cell Metab"},{"issue":"10","key":"1363_CR28","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/jbmr.2527","volume":"30","author":"O Andrukhova","year":"2015","unstructured":"Andrukhova O, Slavic S, Odorfer KI, Erben RG. Experimental myocardial infarction upregulates circulating fibroblast growth factor-23. J Bone Miner Res. 2015;30(10):1831\u20139.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1363_CR29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbrc.2016.01.034","volume":"470","author":"B Zhang","year":"2016","unstructured":"Zhang B, Umbach AT, Chen H, Yan J, Fakhri H, Fajol A, Salker MS, Spichtig D, Daryadel A, Wagner CA, et al. Up-regulation of FGF23 release by aldosterone. Biochem Biophys Res Commun. 2016;470(2):384\u201390.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1363_CR30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","volume":"6","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova O, Slavic S, Smorodchenko A, Zeitz U, Shalhoub V, Lanske B, Pohl EE, Erben RG. FGF23 regulates renal sodium handling and blood pressure. EMBO Mol Med. 2014;6(6):744\u201359.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"1363_CR31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","volume":"25","author":"JJ Scialla","year":"2014","unstructured":"Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE, et al. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014;25(2):349\u201360.","journal-title":"J Am Soc Nephrol"},{"issue":"21","key":"1363_CR32","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/eurheartj\/ehr215","volume":"32","author":"S Seiler","year":"2011","unstructured":"Seiler S, Cremers B, Rebling NM, Hornof F, Jeken J, Kersting S, Steimle C, Ege P, Fehrenz M, Rogacev KS, et al. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. Eur Heart J. 2011;32(21):2688\u201396.","journal-title":"Eur Heart J"},{"issue":"6","key":"1363_CR33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2362.2011.02631.x","volume":"42","author":"M Plischke","year":"2012","unstructured":"Plischke M, Neuhold S, Adlbrecht C, Bielesz B, Shayganfar S, Bieglmayer C, Szekeres T, Horl WH, Strunk G, Vavken P, et al. Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure. Eur J Clin Invest. 2012;42(6):649\u201356.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"1363_CR34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.113.005499","volume":"130","author":"JS Mathew","year":"2014","unstructured":"Mathew JS, Sachs MC, Katz R, Patton KK, Heckbert SR, Hoofnagle AN, Alonso A, Chonchol M, Deo R, Ix JH, et al. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS). Circulation. 2014;130(4):298\u2013307.","journal-title":"Circulation"},{"issue":"5","key":"1363_CR35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamacardio.2016.1445","volume":"1","author":"R Mehta","year":"2016","unstructured":"Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, et al. Association of fibroblast growth factor 23 with atrial fibrillation in chronic kidney disease, from the chronic renal insufficiency cohort study. JAMA Cardiol. 2016;1(5):548\u201356.","journal-title":"JAMA Cardiol"},{"issue":"7","key":"1363_CR36","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","volume":"122","author":"V Shalhoub","year":"2012","unstructured":"Shalhoub V, Shatzen EM, Ward SC, Davis J, Stevens J, Bi V, Renshaw L, Hawkins N, Wang W, Chen C, et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Investig. 2012;122(7):2543\u201353.","journal-title":"J Clin Investig"},{"issue":"11","key":"1363_CR37","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/ndt\/gfu190","volume":"29","author":"GS Marco Di","year":"2014","unstructured":"Di Marco GS, Reuter S, Kentrup D, Grabner A, Amaral AP, Fobker M, Stypmann J, Pavenstadt H, Wolf M, Faul C, et al. Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD. Nephrol Dial Transpl. 2014;29(11):2028\u201335.","journal-title":"Nephrol Dial Transpl"},{"issue":"26","key":"1363_CR38","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"ET Investigators","year":"2012","unstructured":"Investigators ET, Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012;367(26):2482\u201394.","journal-title":"N Engl J Med"},{"issue":"1","key":"1363_CR39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","volume":"132","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drueke TB, Herzog CA, London GM, Mahaffey KW, et al. Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. Circulation. 2015;132(1):27\u201339.","journal-title":"Circulation"},{"issue":"6","key":"1363_CR40","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","volume":"66","author":"KR Neves","year":"2004","unstructured":"Neves KR, Graciolli FG, dos Reis LM, Pasqualucci CA, Moyses RM, Jorgetti V. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int. 2004;66(6):2237\u201344.","journal-title":"Kidney Int"},{"issue":"1","key":"1363_CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1081\/JDI-100001291","volume":"23","author":"P Strozecki","year":"2001","unstructured":"Strozecki P, Adamowicz A, Nartowicz E, Odrowaz-Sypniewska G, Wlodarczyk Z, Manitius J. Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients. Ren Fail. 2001;23(1):115\u201326.","journal-title":"Ren Fail"},{"issue":"4","key":"1363_CR42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2796.2005.01544.x","volume":"258","author":"F Galetta","year":"2005","unstructured":"Galetta F, Cupisti A, Franzoni F, Femia FR, Rossi M, Barsotti G, Santoro G. Left ventricular function and calcium phosphate plasma levels in uraemic patients. J Intern Med. 2005;258(4):378\u201384.","journal-title":"J Intern Med"},{"key":"1363_CR43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijcard.2016.06.181","volume":"221","author":"J Zou","year":"2016","unstructured":"Zou J, Yu Y, Wu P, Lin FJ, Yao Y, Xie Y, Jiang GR. Serum phosphorus is related to left ventricular remodeling independent of renal function in hospitalized patients with chronic kidney disease. Int J Cardiol. 2016;221:134\u201340.","journal-title":"Int J Cardiol"},{"issue":"9","key":"1363_CR44","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2005040392","volume":"16","author":"JC Ayus","year":"2005","unstructured":"Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005;16(9):2778\u201388.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"1363_CR45","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1681\/ASN.V4101814","volume":"4","author":"K Amann","year":"1994","unstructured":"Amann K, Ritz E, Wiest G, Klaus G, Mall G. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol. 1994;4(10):1814\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1363_CR46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/jcem.82.1.3666","volume":"82","author":"T Stefenelli","year":"1997","unstructured":"Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab. 1997;82(1):106\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"1363_CR47","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","volume":"24","author":"FN Saleh","year":"2003","unstructured":"Saleh FN, Schirmer H, Sundsfjord J, Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J. 2003;24(22):2054\u201360.","journal-title":"Eur Heart J"},{"issue":"20","key":"1363_CR48","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.ehj.2004.07.010","volume":"25","author":"P Andersson","year":"2004","unstructured":"Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease\u2014a review. Eur Heart J. 2004;25(20):1776\u201387.","journal-title":"Eur Heart J"},{"key":"1363_CR49","doi-asserted-by":"crossref","unstructured":"Fujii H, Kim JI, Abe T, Umezu M, Fukagawa M. Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis patients. Intern Med (Tokyo, Japan). 2007; 46(18):1507\u20131512.","DOI":"10.2169\/internalmedicine.46.0269"},{"issue":"9","key":"1363_CR50","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jash.2015.06.020","volume":"9","author":"AA Soares","year":"2015","unstructured":"Soares AA, Freitas WM, Japiassu AV, Quaglia LA, Santos SN, Pereira AC, Nadruz Junior W, Sposito AC. Enhanced parathyroid hormone levels are associated with left ventricle hypertrophy in very elderly men and women. J Am Soc Hyperten JASH. 2015;9(9):697\u2013704.","journal-title":"J Am Soc Hyperten JASH"},{"issue":"1\u20132","key":"1363_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000347145","volume":"122","author":"SR Choi","year":"2012","unstructured":"Choi SR, Lim JH, Kim MY, Hong YA, Chung BH, Chung S, Choi BS, Yang CW, Kim YS, Chang YS, et al. Cinacalcet improves endothelial dysfunction and cardiac hypertrophy in patients on hemodialysis with secondary hyperparathyroidism. Nephron Clin Pract. 2012;122(1\u20132):1\u20138.","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"1363_CR52","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","volume":"97","author":"S Pilz","year":"2012","unstructured":"Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, Meinitzer A, Marz W, Pieber TR, Tomaschitz A. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. J Clin Endocrinol Metab. 2012;97(1):E75\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1363_CR53","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1380543","volume":"138","author":"L Kovacs","year":"1998","unstructured":"Kovacs L, Goth MI, Szabolcs I, Dohan O, Ferencz A, Szilagyi G. The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism. Eur J Endocrinol Eur Fed Endocrine Soc. 1998;138(5):543\u20137.","journal-title":"Eur J Endocrinol Eur Fed Endocrine Soc"},{"key":"1363_CR54","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ijcard.2015.03.062","volume":"184","author":"A Tomaschitz","year":"2015","unstructured":"Tomaschitz A, Pilz S, Rus-Machan J, Meinitzer A, Brandenburg VM, Scharnagl H, Kapl M, Grammer T, Ritz E, Horina JH, et al. Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk. Int J Cardiol. 2015;184:710\u20136.","journal-title":"Int J Cardiol"},{"issue":"6","key":"1363_CR55","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/eurjhf\/hfr016","volume":"13","author":"LL Schierbeck","year":"2011","unstructured":"Schierbeck LL, Jensen TS, Bang U, Jensen G, Kober L, Jensen JE. Parathyroid hormone and vitamin D\u2014markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail. 2011;13(6):626\u201332.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1363_CR56","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2014050465","volume":"26","author":"MC Hu","year":"2015","unstructured":"Hu MC, Shi M, Cho HJ, Adams-Huet B, Paek J, Hill K, Shelton J, Amaral AP, Faul C, Taniguchi M, et al. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol. 2015;26(6):1290\u2013302.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1363_CR57","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1681\/ASN.2014040325","volume":"26","author":"J Xie","year":"2015","unstructured":"Xie J, Yoon J, An SW, Kuro-o M, Huang CL. Soluble Klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate. J Am Soc Nephrol. 2015;26(5):1150\u201360.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1363_CR58","doi-asserted-by":"crossref","first-page":"e73184","DOI":"10.1371\/journal.pone.0073184","volume":"8","author":"K Shibata","year":"2013","unstructured":"Shibata K, Fujita S, Morita H, Okamoto Y, Sohmiya K, Hoshiga M, Ishizaka N. Association between circulating fibroblast growth factor 23, alpha-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients. PLoS One. 2013;8(9):e73184.","journal-title":"PLoS One"},{"issue":"4","key":"1363_CR59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607\u201317.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"1363_CR60","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","volume":"87","author":"S Jono","year":"2000","unstructured":"Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87(7):E10\u20137.","journal-title":"Circ Res"},{"issue":"5","key":"1363_CR61","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","volume":"62","author":"NX Chen","year":"2002","unstructured":"Chen NX, O\u2019Neill KD, Duan D, Moe SM. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002;62(5):1724\u201331.","journal-title":"Kidney Int"},{"issue":"2","key":"1363_CR62","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","volume":"61","author":"SM Moe","year":"2002","unstructured":"Moe SM, O\u2019Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002;61(2):638\u201347.","journal-title":"Kidney Int"},{"issue":"1","key":"1363_CR63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2009060640","volume":"21","author":"RC Shroff","year":"2010","unstructured":"Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield J, Rees L, Shanahan CM. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol. 2010;21(1):103\u201312.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1363_CR64","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16(2):520\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1363_CR65","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","volume":"167","author":"R Dhingra","year":"2007","unstructured":"Dhingra R, Sullivan LM, Fox CS, Wang TJ, D\u2019Agostino RB Sr, Gaziano JM, Vasan RS. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007;167(9):879\u201385.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1363_CR66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/aje\/kwn285","volume":"169","author":"SJ Onufrak","year":"2009","unstructured":"Onufrak SJ, Bellasi A, Cardarelli F, Vaccarino V, Muntner P, Shaw LJ, Raggi P. Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality. Am J Epidemiol. 2009;169(1):67\u201377.","journal-title":"Am J Epidemiol"},{"issue":"26","key":"1363_CR67","doi-asserted-by":"crossref","first-page":"10741","DOI":"10.1073\/pnas.1308814110","volume":"110","author":"A Kelly-Arnold","year":"2013","unstructured":"Kelly-Arnold A, Maldonado N, Laudier D, Aikawa E, Cardoso L, Weinbaum S. Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries. Proc Natl Acad Sci USA. 2013;110(26):10741\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"40","key":"1363_CR68","doi-asserted-by":"crossref","first-page":"14678","DOI":"10.1073\/pnas.0606310103","volume":"103","author":"Y Vengrenyuk","year":"2006","unstructured":"Vengrenyuk Y, Carlier S, Xanthos S, Cardoso L, Ganatos P, Virmani R, Einav S, Gilchrist L, Weinbaum S. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci USA. 2006;103(40):14678\u201383.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1363_CR69","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ki.1995.356","volume":"48","author":"T Kawagishi","year":"1995","unstructured":"Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48(3):820\u20136.","journal-title":"Kidney Int"},{"issue":"6","key":"1363_CR70","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjcard.2010.05.004","volume":"106","author":"L Ruan","year":"2010","unstructured":"Ruan L, Chen W, Srinivasan SR, Xu J, Toprak A, Berenson GS. Relation of serum phosphorus levels to carotid intima-media thickness in asymptomatic young adults (from the Bogalusa Heart Study). Am J Cardiol. 2010;106(6):793\u20137.","journal-title":"Am J Cardiol"},{"issue":"1","key":"1363_CR71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5273(97)02971-9","volume":"60","author":"R Narang","year":"1997","unstructured":"Narang R, Ridout D, Nonis C, Kooner JS. Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol. 1997;60(1):73\u20139.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1363_CR72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1681\/ASN.2004060495","volume":"16","author":"ZA Massy","year":"2005","unstructured":"Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drueke TB, et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol. 2005;16(1):109\u201316.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1363_CR73","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/01.ASN.0000068404.57780.DD","volume":"14","author":"MR Davies","year":"2003","unstructured":"Davies MR, Lund RJ, Hruska KA. BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol. 2003;14(6):1559\u201367.","journal-title":"J Am Soc Nephrol"},{"issue":"18","key":"1363_CR74","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1161\/CIRCULATIONAHA105.541854","volume":"112","author":"O Phan","year":"2005","unstructured":"Phan O, Ivanovski O, Nguyen-Khoa T, Mothu N, Angulo J, Westenfeld R, Ketteler M, Meert N, Maizel J, Nikolov IG, et al. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation. 2005;112(18):2875\u201382.","journal-title":"Circulation"},{"issue":"1","key":"1363_CR75","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ndt\/gfm699","volume":"23","author":"O Phan","year":"2008","unstructured":"Phan O, Ivanovski O, Nikolov IG, Joki N, Maizel J, Louvet L, Chasseraud M, Nguyen-Khoa T, Lacour B, Drueke TB, et al. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE\u2212\/\u2212) mice with chronic renal failure. Nephrol Dial Transpl. 2008;23(1):82\u201390.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"1363_CR76","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1159\/000313492","volume":"115","author":"IG Nikolov","year":"2010","unstructured":"Nikolov IG, Joki N, Vicca S, Patey N, Auchere D, Benchitrit J, Flinois JP, Ziol M, Beaune P, Drueke TB, et al. Tissue accumulation of lanthanum as compared to aluminum in rats with chronic renal failure\u2014possible harmful effects after long-term exposure. Nephron Exp Nephrol. 2010;115(4):e112\u201321.","journal-title":"Nephron Exp Nephrol"},{"issue":"16","key":"1363_CR77","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","volume":"124","author":"NM Rajamannan","year":"2011","unstructured":"Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, Simmons CA, Masters KS, Mathieu P, O\u2019Brien KD, et al. Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease\u20142011 update. Circulation. 2011;124(16):1783\u201391.","journal-title":"Circulation"},{"issue":"19","key":"1363_CR78","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","volume":"60","author":"MR Dweck","year":"2012","unstructured":"Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol. 2012;60(19):1854\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1363_CR79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000441-200304000-00010","volume":"325","author":"E Umana","year":"2003","unstructured":"Umana E, Ahmed W, Alpert MA. Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci. 2003;325(4):237\u201342.","journal-title":"Am J Med Sci"},{"issue":"12","key":"1363_CR80","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1093\/ndt\/gft310","volume":"28","author":"M Rattazzi","year":"2013","unstructured":"Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P. Aortic valve calcification in chronic kidney disease. Nephrol Dial Transpl. 2013;28(12):2968\u201376.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"1363_CR81","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199907153410302","volume":"341","author":"CM Otto","year":"1999","unstructured":"Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341(3):142\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"1363_CR82","first-page":"429","volume":"18","author":"Y Leskinen","year":"2009","unstructured":"Leskinen Y, Paana T, Saha H, Groundstroem K, Lehtimaki T, Kilpinen S, Huhtala H, Airaksinen J. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. J Heart Valve Dis. 2009;18(4):429\u201338.","journal-title":"J Heart Valve Dis"},{"issue":"5","key":"1363_CR83","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/ndt\/gfq596","volume":"26","author":"D Zentner","year":"2011","unstructured":"Zentner D, Hunt D, Chan W, Barzi F, Grigg L, Perkovic V. Prospective evaluation of aortic stenosis in end-stage kidney disease: a more fulminant process? Nephrol Dial Transpl. 2011;26(5):1651\u20135.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"1363_CR84","first-page":"217","volume":"20","author":"P Urena","year":"1999","unstructured":"Urena P, Malergue MC, Goldfarb B, Prieur P, Guedon-Rapoud C, Petrover M. Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors. Nephrologie. 1999;20(4):217\u201325.","journal-title":"Nephrologie"},{"issue":"12","key":"1363_CR85","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.amjcard.2016.03.048","volume":"117","author":"D Kim","year":"2016","unstructured":"Kim D, Shim CY, Hong GR, Cho IJ, Chang HJ, Ha JW, Chung N. Effect of end-stage renal disease on rate of progression of aortic stenosis. Am J Cardiol. 2016;117(12):1972\u20137.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1363_CR86","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1681\/ASN.2005060627","volume":"17","author":"CS Fox","year":"2006","unstructured":"Fox CS, Larson MG, Vasan RS, Guo CY, Parise H, Levy D, Leip EP, O\u2019Donnell CJ, D\u2019Agostino RB Sr, Benjamin EJ. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol. 2006;17(2):521\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1363_CR87","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.ajkd.2007.05.020","volume":"50","author":"JH Ix","year":"2007","unstructured":"Ix JH, Shlipak MG, Katz R, Budoff MJ, Shavelle DM, Probstfield JL, Takasu J, Detrano R, O\u2019Brien KD. Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2007;50(3):412\u201320.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1363_CR88","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ndt\/gfn544","volume":"24","author":"FW Asselbergs","year":"2009","unstructured":"Asselbergs FW, Mozaffarian D, Katz R, Kestenbaum B, Fried LF, Gottdiener JS, Shlipak MG, Siscovick DS. Association of renal function with cardiac calcifications in older adults: the cardiovascular health study. Nephrol Dial Transpl. 2009;24(3):834\u201340.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"1363_CR89","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM199208063270602","volume":"327","author":"EJ Benjamin","year":"1992","unstructured":"Benjamin EJ, Plehn JF, D\u2019Agostino RB, Belanger AJ, Comai K, Fuller DL, Wolf PA, Levy D. Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med. 1992;327(6):374\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"1363_CR90","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.amjcard.2009.10.065","volume":"105","author":"K Akat","year":"2010","unstructured":"Akat K, Kaden JJ, Schmitz F, Ewering S, Anton A, Klomfass S, Hoffmann R, Ortlepp JR. Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. Am J Cardiol. 2010;105(6):862\u20134.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1363_CR91","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1797.2006.00696.x","volume":"11","author":"F Tarrass","year":"2006","unstructured":"Tarrass F, Benjelloun M, Zamd M, Medkouri G, Hachim K, Benghanem MG, Ramdani B. Heart valve calcifications in patients with end-stage renal disease: analysis for risk factors. Nephrology (Carlton). 2006;11(6):494\u20136.","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"1363_CR92","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","volume":"17","author":"M Taniguchi","year":"2013","unstructured":"Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K, Tsubakihara Y, et al. Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial. 2013;17(2):221\u20138.","journal-title":"Ther Apher Dial"},{"issue":"17","key":"1363_CR93","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. Cholesterol, Recurrent Events Trial I: relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112(17):2627\u201333.","journal-title":"Circulation"},{"issue":"2","key":"1363_CR94","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2013.12.051","volume":"233","author":"JP Linefsky","year":"2014","unstructured":"Linefsky JP, O\u2019Brien KD, Sachs M, Katz R, Eng J, Michos ED, Budoff MJ, de Boer I, Kestenbaum B. Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2014;233(2):331\u20137.","journal-title":"Atherosclerosis"},{"issue":"1","key":"1363_CR95","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2011-2107","volume":"97","author":"S Iwata","year":"2012","unstructured":"Iwata S, Walker MD, Di Tullio MR, Hyodo E, Jin Z, Liu R, Sacco RL, Homma S, Silverberg SJ. Aortic valve calcification in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2012;97(1):132\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1363_CR96","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijcard.2011.06.025","volume":"163","author":"S Iwata","year":"2013","unstructured":"Iwata S, Hyodo E, Yanagi S, Hayashi Y, Nishiyama H, Kamimori K, Ota T, Matsumura Y, Homma S, Yoshiyama M. Parathyroid hormone and systolic blood pressure accelerate the progression of aortic valve stenosis in chronic hemodialysis patients. Int J Cardiol. 2013;163(3):256\u20139.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1363_CR97","first-page":"262","volume":"18","author":"F Schmitz","year":"2009","unstructured":"Schmitz F, Ewering S, Zerres K, Klomfass S, Hoffmann R, Ortlepp JR. Parathyroid hormone gene variant and calcific aortic stenosis. J Heart Valve Dis. 2009;18(3):262\u20137.","journal-title":"J Heart Valve Dis"},{"issue":"7","key":"1363_CR98","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0735-1097(03)00090-1","volume":"41","author":"MC Drolet","year":"2003","unstructured":"Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol. 2003;41(7):1211\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"1\u20133","key":"1363_CR99","first-page":"290","volume":"590","author":"DT Ngo","year":"2008","unstructured":"Ngo DT, Stafford I, Kelly DJ, Sverdlov AL, Wuttke RD, Weedon H, Nightingale AK, Rosenkranz AC, Smith MD, Chirkov YY, et al. Vitamin D(2) supplementation induces the development of aortic stenosis in rabbits: interactions with endothelial function and thioredoxin-interacting protein. Eur J Pharmacol. 2008;590(1\u20133):290\u20136.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"1363_CR100","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/ndt\/gfs046","volume":"27","author":"TB Drueke","year":"2012","unstructured":"Drueke TB, Massy ZA. Role of vitamin D in vascular calcification: bad guy or good guy? Nephrol Dial Transpl. 2012;27(5):1704\u20137.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"1363_CR101","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.atherosclerosis.2014.10.027","volume":"237","author":"M Rattazzi","year":"2014","unstructured":"Rattazzi M, Bertacco E, Iop L, D\u2019Andrea S, Puato M, Buso G, Causin V, Gerosa G, Faggin E, Pauletto P. Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: implications for aortic valve calcification. Atherosclerosis. 2014;237(2):568\u201376.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1363_CR102","first-page":"387","volume":"23","author":"S Rathan","year":"2014","unstructured":"Rathan S, Yoganathan AP, O\u2019Neill CW. The role of inorganic pyrophosphate in aortic valve calcification. J Heart Valve Dis. 2014;23(4):387\u201394.","journal-title":"J Heart Valve Dis"},{"issue":"7","key":"1363_CR103","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/ATVBAHA.116.307526","volume":"36","author":"MV Gomez-Stallons","year":"2016","unstructured":"Gomez-Stallons MV, Wirrig-Schwendeman EE, Hassel KR, Conway SJ, Yutzey KE. Bone morphogenetic protein signaling is required for aortic valve calcification. Arterioscler Thromb Vasc Biol. 2016;36(7):1398\u2013405.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1363_CR104","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353(3):238\u201348.","journal-title":"N Engl J Med"},{"issue":"3","key":"1363_CR105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/j.ajkd.2012.09.017","volume":"61","author":"M Moroi","year":"2013","unstructured":"Moroi M, Tamaki N, Nishimura M, Haze K, Nishimura T, Kusano E, Akiba T, Sugimoto T, Hase H, Hara K, et al. Association between abnormal myocardial fatty acid metabolism and cardiac-derived death among patients undergoing hemodialysis: results from a cohort study in Japan. Am J Kidney Dis. 2013;61(3):466\u201375.","journal-title":"Am J Kidney Dis"},{"key":"1363_CR106","doi-asserted-by":"crossref","unstructured":"Nie Y, Zou J, Liang Y, Shen B, Liu Z, Cao X, Chen X, Ding X. Electrocardiographic abnormalities and qtc interval in patients undergoing hemodialysis. PloS one. 2016.","DOI":"10.1371\/journal.pone.0155445"},{"key":"1363_CR107","doi-asserted-by":"crossref","unstructured":"Temiz G, Yalcin AU, Mutluay R, Bozaci I, Bal C. Effects of cinacalcet treatment on QT interval in hemodialysis patients. Anatol J Cardiol. 2015.","DOI":"10.5152\/AnatolJCardiol.2015.6284"},{"issue":"6","key":"1363_CR108","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/europace\/eun028","volume":"10","author":"S Genovesi","year":"2008","unstructured":"Genovesi S, Dossi C, Vigano MR, Galbiati E, Prolo F, Stella A, Stramba-Badiale M. Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. Europace Eur Pacing Arrhythm Cardiac Electrophysiol J Working Groups Cardiac Pacing Arrhythm Cardiac Cell Electrophysiol Eur Soc Cardiol. 2008;10(6):771\u20137.","journal-title":"Europace Eur Pacing Arrhythm Cardiac Electrophysiol J Working Groups Cardiac Pacing Arrhythm Cardiac Cell Electrophysiol Eur Soc Cardiol"},{"issue":"5","key":"1363_CR109","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2215\/CJN.10000912","volume":"8","author":"PH Pun","year":"2013","unstructured":"Pun PH, Horton JR, Middleton JP. Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8(5):797\u2013803.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"1363_CR110","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/sj.ki.5000446","volume":"69","author":"AJ Bleyer","year":"2006","unstructured":"Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int. 2006;69(12):2268\u201373.","journal-title":"Kidney Int"},{"issue":"12","key":"1363_CR111","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jacc.2014.12.049","volume":"65","author":"MC Wong","year":"2015","unstructured":"Wong MC, Kalman JM, Pedagogos E, Toussaint N, Vohra JK, Sparks PB, Sanders P, Kistler PM, Halloran K, Lee G, et al. Bradycardia and asystole is the predominant mechanism of sudden cardiac death in patients with chronic kidney disease. J Am Coll Cardiol. 2015;65(12):1263\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1363_CR112","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF03007262","volume":"28","author":"F Bylsma","year":"1981","unstructured":"Bylsma F, Walmsley JB. Metastatic myocardial calcification. Can Anaesth Soc J. 1981;28(2):167\u20139.","journal-title":"Can Anaesth Soc J"},{"issue":"4","key":"1363_CR113","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000343497","volume":"2","author":"M Matsui","year":"2012","unstructured":"Matsui M, Okayama S, Takitsume A, Morimoto K, Samejima K, Uemura S, Saito Y. Heart failure associated with metastatic myocardial calcification in a hemodialysis patient with progressive calcification of the hand. Cardiorenal Med. 2012;2(4):251\u20135.","journal-title":"Cardiorenal Med"},{"issue":"19","key":"1363_CR114","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/eurheartj\/ehm100","volume":"28","author":"CJ Lee","year":"2007","unstructured":"Lee CJ, Ramirez C, Thomson LE. A stone heart: fatal cardiac microcalcification. Eur Heart J. 2007;28(19):2312.","journal-title":"Eur Heart J"},{"issue":"22","key":"1363_CR115","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1056\/NEJM197106032842208","volume":"284","author":"RR Henderson","year":"1971","unstructured":"Henderson RR, Santiago LM, Spring DA, Harrington AR. Metastatic myocardial calcification in chronic renal failure presenting as atrioventricular block. N Engl J Med. 1971;284(22):1252\u20133.","journal-title":"N Engl J Med"},{"issue":"Suppl 8","key":"1363_CR116","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1034\/j.1399-0012.16.s8.3.x","volume":"16","author":"M Okada","year":"2002","unstructured":"Okada M, Kyakuno M, Imamura J, Nakamura T, Takahara S. An autopsy case of sudden death in renal transplant recipient. Clin Transpl. 2002;16(Suppl 8):58\u201361.","journal-title":"Clin Transpl"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1363-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-016-1363-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1363-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T21:36:46Z","timestamp":1658353006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-016-1363-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,6]]},"references-count":116,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1363"],"URL":"https:\/\/doi.org\/10.1007\/s10157-016-1363-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,6]]}}}